Search results
Learn how you can access Psychedelic-Assisted Therapy (PAT) through Health Canada’s SAP program. You can find tips and templates to streamline your application process! Check out the SAP Tip Sheet Here!
18 cze 2015 · Search the Drug Product Database (DPD) to find drugs authorized for sale by Health Canada. The DPD is updated nightly and includes: availability of the drug in Canada. product monograph (PM) for human drugs. labels for animal drugs.
Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related multidisciplinary research, education, and public policy.
The psychedelics landscape experienced notable developments over the last few years, which further support the view that controlled psychedelic substances have a potential positive role in medical treatment of disorders in Canada.
Project Solace is the world's largest medical psilocybin access and data project. This project aims to expand legal access to psilocybin for patients in medical need, while developing a substantial body of evidence, using a real-world data registry.
6 lip 2023 · CAMH’s clinical trial will attempt to answer whether experiencing psilocybin’s psychedelic effects are necessary for the user to experience its potentially antidepressant impacts. The study will recruit 60 adults with treatment-resistant depression over the course of three years, some of whom will receive a placebo.
27 lut 2023 · This notice outlines the information that health care practitioners need to know when applying for access to psychedelic drugs through Health Canada's Special Access Program (SAP) for the purposes of psychedelic-assisted psychotherapy.
